Filing Details

Accession Number:
0001493152-22-036394
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-23 07:01:25
Reporting Period:
2022-12-21
Accepted Time:
2022-12-23 07:01:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1360214 Harrow Health Inc. HROW Pharmaceutical Preparations (2834) 450567010
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1921566 A. Martin Makary C/O Harrow Health, Inc.
102 Woodmont Blvd, Suite 610
Nashville TN 37205
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-21 25,000 $13.37 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.30 to $13.43, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.